Armenia vs Hong Kong: HIV-positive TB patients on ART (antiretroviral therapy)
Armenia
100.0%
in 2024
Hong Kong
100.0%
in 2024
Armenia rank
1st
Hong Kong rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Armenia
- Hong Kong
How they compare
Armenia currently reports 100.0% against 100.0% in Hong Kong, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2005 it was Hong Kong ahead.
Armenia ranks 1st and Hong Kong ranks 1st of 144 countries.
Across the 3 decades both report, Armenia averaged higher in 1 and Hong Kong in 2.
Head to head by decade
| Decade | Armenia | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.1% | 44.8% | 10.7% | Hong Kong |
| 2010s | 86.7% | 31.1% | 55.6% | Armenia |
| 2020s | 90.3% | 94.0% | 3.7% | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Armenia or Hong Kong?
- Armenia, at 100.0% against 100.0% in Hong Kong as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Armenia and Hong Kong?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Hong Kong?
- 14 years are reported by both, from 2005 to 2024.
- How do Armenia and Hong Kong rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Armenia ranks 1st and Hong Kong ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.